Human Molecular Genetics Advance Access published online on March 15, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl050
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Child Health, University College London, 30, Guilford Street, London WC1N 1EH, United Kingdom
* To whom correspondence should be addressed. Null mutations in Artemis confer a condition described as RS-SCID, in which patients display radiosensitivity combined with severe combined immunodeficiency. Here, we characterise the defect in Artemis in a patient who displayed progressive combined immunodeficiency and elevated lymphocyte apoptosis. The patient is a compound heterozygote with novel mutations in both alleles, resulting in Artemis proteins with either L70 deletion or G126D substitution. Both mutational changes impact upon Artemis function and a fibroblast cell line derived from the patient (F96-224) has greatly reduced Artemis protein. In contrast to Artemis null cell lines, which fail to repair a subset of DNA double strand breaks (DSBs) induced by ionising radiation, F96-224 cells show slow but residual DSB rejoining. Despite showing intermediate cellular and clinical features, F96-224 cells are as radiosensitive as Artemis null cell lines. We developed a FACS based assay to examine cell division and cellular characteristics for 10 days following exposure to ionising radiation (2 and 4 Gy). This analysis demonstrated that F96-224 cells show delayed cell death compared to rapid growth arrest of an Artemis null cell line, and the emergence of a cycling population shown by a control line. F96-224 cells also display elevated chromosome aberrations compared to control cells. F96-224 therefore represents a novel phenotype for a hypomorphic cell line. We suggest that delayed cell death contributes to the progressive combined immunodeficiency phenotype of the Artemis patient.
Received January 13, 2006
Revised March 3, 2006
Accepted March 3, 2006
Article
Radiation induced delayed cell death in a hypomorphic Artemis cell line
Paul M. Evans 1,
Lisa Woodbine 2,
Enriquetta Riballo 2,
Andrew R. Gennery 3,
Michael Hubank 1 *,
and
Penny A. Jeggo 2
2 Genome Damage and Stability Centre, University of Sussex, East Sussex, BN1 9RQ, United Kingdom
3 Department of Pediatric Immunology, Newcastle General Hosptial, Westgate Road, Newcastle upon Tyne, NE4 6BE, United Kingdom
Michael Hubank, E-mail: m.hubank{at}ich.ucl.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. R. Gennery Primary immunodeficiency syndromes associated with defective DNA double-strand break repair Br. Med. Bull., October 5, 2006; (2006) ldl006v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Drouet, P. Frit, C. Delteil, J.-P. de Villartay, B. Salles, and P. Calsou Interplay between Ku, Artemis, and the DNA-dependent Protein Kinase Catalytic Subunit at DNA Ends J. Biol. Chem., September 22, 2006; 281(38): 27784 - 27793. [Abstract] [Full Text] [PDF] |
||||

